CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300869 Contec Medical Systems
- 13.60
- +0.34+2.56%
Market Closed Apr 30 15:00 CST
5.46BMarket Cap-82.93P/E (TTM)
14.05High13.32Low76.49KlotVolume13.40Open13.26Pre Close105.15MTurnover3.02%Turnover RatioLossP/E (Static)401.80MShares19.5452wk High2.96P/B3.45BFloat Cap11.5852wk Low15.91Limit Up253.36MShs Float307.03Historical High10.61Limit Down5.51%Amplitude11.58Historical Low0.30Dividend TTM13.75Avg Price37.63KlotAsk2.21%Div YieldTTM100Lot Size36.88KlotBid
Contec Medical Systems Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.77%111.84M | -35.76%479.81M | -45.91%333.89M | -57.17%211.79M | -73.10%99.18M | 4.89%746.9M | 33.55%617.23M | 48.88%494.48M | 101.21%368.7M | -21.63%712.11M |
| Operating revenue | 12.77%111.84M | -35.76%479.81M | -45.91%333.89M | -57.17%211.79M | -73.10%99.18M | 4.89%746.9M | 33.55%617.23M | 48.88%494.48M | 101.21%368.7M | -21.63%712.11M |
| Other operating revenue | ---- | -12.27%3.73M | ---- | -9.36%1.98M | ---- | 23.90%4.25M | ---- | 25.99%2.18M | ---- | -11.27%3.43M |
| Total operating cost | -8.47%93.52M | -17.79%467.67M | -21.55%336.66M | -31.66%212.97M | -48.18%102.18M | 3.12%568.89M | 55.53%429.15M | 52.71%311.66M | 90.79%197.19M | 8.21%551.7M |
| Operating cost | -6.74%46.81M | -23.29%243.02M | -35.23%167.27M | -44.24%106.96M | -62.06%50.19M | -15.29%316.82M | 3.39%258.24M | 5.01%191.84M | 32.28%132.3M | -19.17%374.02M |
| Operating tax surcharges | 24.03%3.47M | -34.16%8.46M | -40.55%6.52M | -49.30%4.53M | -59.55%2.8M | 27.82%12.85M | 116.91%10.98M | 319.40%8.94M | 686.57%6.92M | 61.25%10.06M |
| Operating expense | -1.92%15.86M | -24.78%88.53M | -28.64%56.44M | -40.77%36.43M | -52.89%16.17M | 30.46%117.69M | 114.04%79.1M | 147.98%61.5M | 258.01%34.33M | 36.46%90.21M |
| Administration expense | -25.21%8.07M | -2.29%40.82M | -17.63%26.68M | -21.69%17.83M | -25.13%10.8M | 21.32%41.78M | 60.31%32.4M | 64.24%22.76M | 88.11%14.42M | 4.85%34.44M |
| Financial expense | 33.51%-3.28M | 40.63%-18.32M | 88.26%-3.68M | 64.50%-8.83M | 68.79%-4.93M | 38.64%-30.85M | 69.30%-31.35M | 58.99%-24.88M | 53.92%-15.78M | 59.50%-50.28M |
| -Interest expense (Financial expense) | ---- | -21.74%35.3M | ---- | ---- | ---- | 136.39%45.1M | ---- | ---- | ---- | 566.46%19.08M |
| -Interest Income (Financial expense) | ---- | 40.21%-48.54M | ---- | ---- | ---- | 3.67%-81.18M | ---- | ---- | ---- | -25.68%-84.27M |
| Research and development | -16.83%22.57M | -4.92%105.16M | 4.54%83.43M | 8.85%56.06M | 8.54%27.14M | 18.60%110.6M | 20.79%79.81M | 24.77%51.5M | 28.52%25.01M | 41.16%93.25M |
| Credit Impairment Loss | 99.29%-4.77K | -268.49%-1.82M | -455.54%-1.19M | -387.57%-1.42M | -912.02%-670.64K | 152.76%1.08M | 118.03%333.74K | 72.44%-291.02K | 265.87%82.59K | -456.30%-2.05M |
| Asset Impairment Loss | -115.36%-6.87M | -179.84%-109.45M | -3.17%-8.76M | 16.31%-6.13M | 0.90%-3.19M | -569.24%-39.11M | -77.12%-8.49M | -124.23%-7.32M | -171.47%-3.22M | 45.41%-5.84M |
| Other net revenue | -118.98%-1.1M | -1,013.61%-79.68M | -58.94%13.25M | -67.33%9.09M | -65.21%5.81M | -85.18%8.72M | 242.49%32.27M | 1,537.76%27.83M | 891.11%16.7M | 755.65%58.86M |
| Fair value change income | 309.86%2.31M | -21.52%1.59M | 101.97%916.58K | 103.32%1.55M | 102.50%562.92K | -95.66%2.02M | -644.60%-46.58M | ---46.63M | ---22.52M | --46.64M |
| Invest income | -91.37%664.12K | 96.35%22.52M | -73.10%15.36M | -80.21%11.1M | -71.86%7.7M | 44.10%11.47M | --57.11M | --56.07M | --27.35M | 402.85%7.96M |
| Asset deal income | 41.73%-16.32K | 345.19%166.24K | 3,050.02%166.24K | 240.84%7.94K | ---28K | 73.90%-67.8K | ---5.64K | ---5.64K | ---- | -493.85%-259.79K |
| Other revenue | 95.82%2.82M | -78.07%7.31M | -77.41%6.76M | -84.68%3.98M | -90.41%1.44M | 168.42%33.33M | 297.91%29.9M | 331.91%26.01M | 413.61%15M | -24.35%12.42M |
| Operating profit | 513.50%17.22M | -136.17%-67.55M | -95.25%10.47M | -96.25%7.91M | -98.51%2.81M | -14.84%186.73M | 12.60%220.34M | 62.36%210.65M | 130.73%188.21M | -45.96%219.28M |
| Add:Non operating Income | -68.25%189.89K | 241.73%1.63M | 218.34%1.38M | 819.40%1.18M | 1,346.02%598.03K | -1.45%476.33K | 62.58%432.28K | 4,240.21%128.5K | 8,408.73%41.36K | -81.62%483.35K |
| Less:Non operating expense | -6.30%268.39K | 634.38%7.96M | 13.85%690.12K | 16.72%583.37K | -7.97%286.45K | 197.36%1.08M | 159.23%606.17K | 191.94%499.82K | 759.89%311.25K | -4.47%364.73K |
| Total profit | 449.70%17.15M | -139.70%-73.89M | -94.93%11.16M | -95.96%8.5M | -98.34%3.12M | -15.16%186.13M | 12.50%220.17M | 62.28%210.28M | 130.50%187.94M | -46.23%219.39M |
| Less:Income tax cost | 157.65%710.67K | -80.28%4.02M | -94.99%1.26M | -98.77%337.21K | -106.89%-1.23M | -12.21%20.36M | 16.50%25.05M | 92.88%27.39M | 117.39%17.88M | -58.32%23.19M |
| Net profit | 277.67%16.44M | -147.00%-77.9M | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | 58.51%182.89M | 131.97%170.05M | -44.32%196.2M |
| Net profit from continuing operation | 277.67%16.44M | -147.00%-77.9M | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | --182.89M | 131.97%170.05M | -44.32%196.2M |
| Net profit of parent company owners | 277.67%16.44M | -147.00%-77.9M | -94.92%9.9M | -95.53%8.17M | -97.44%4.35M | -15.51%165.77M | 12.00%195.12M | 58.51%182.89M | 131.97%170.05M | -44.32%196.2M |
| Earning per share | ||||||||||
| Basic earning per share | 278.70%0.0409 | -146.34%-0.19 | -94.93%0.0246 | -95.65%0.02 | -97.45%0.0108 | -16.33%0.41 | 11.99%0.4856 | 58.62%0.46 | 131.89%0.4232 | -44.32%0.49 |
| Diluted earning per share | ---- | -142.50%-0.17 | ---- | ---- | ---- | -16.67%0.4 | 13.25%0.4625 | ---- | --0 | --0.48 |
| Other composite income | 202.46%138.6K | -47.94%396.63K | -153.58%-713.85K | -95.14%78.99K | 75.83%-135.26K | -74.54%761.8K | -64.36%1.33M | -1.46%1.63M | 32.88%-559.57K | 544.19%2.99M |
| Other composite income of parent company owners | 202.46%138.6K | -47.94%396.63K | -153.58%-713.85K | -95.14%78.99K | 75.83%-135.26K | -74.54%761.8K | -64.36%1.33M | -1.46%1.63M | 32.88%-559.57K | 544.19%2.99M |
| Total composite income | 293.07%16.57M | -146.54%-77.51M | -95.32%9.19M | -95.53%8.25M | -97.51%4.22M | -16.40%166.53M | 10.40%196.45M | 57.67%184.51M | 133.87%169.49M | -43.36%199.2M |
| Total composite income of parent company owners | 293.07%16.57M | -146.54%-77.51M | -95.32%9.19M | -95.53%8.25M | -97.51%4.22M | -16.40%166.53M | 10.40%196.45M | 57.67%184.51M | 133.87%169.49M | -43.36%199.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.